|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5383 | |
| A61K 31/5395 | |||
| A61K 9/00 | |||
| A61P 31/04 | |||
| A61P 27/02 | |||
| A61K 31/535 | |||
| A61K 45/06 |
| (11) | Number of the document | 2448587 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10732580.5 |
| Date of filing the European patent application | 2010-07-02 | |
| (97) | Date of publication of the European application | 2012-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/040956 |
| Date | 2010-07-02 |
| (87) | Number | WO 2011/003091 |
| Date | 2011-01-06 |
| (30) | Number | Date | Country code |
| 222625 P | 2009-07-02 | US |
| (72) |
STROMAN, David, W., US
CHOWHAN, Masood, A., US
APPELL, Kenneth, C., US
|
| (73) |
MerLion Pharmaceuticals Pte., Ltd.,
10 Raeburn Park, No. 02-08, Singapore 088702,
SG
|
| (54) | COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS |
| COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS |